| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mannose-Binding Lectin | 46 | 2016 | 146 | 5.850 |
Why?
|
| Complement Activation | 18 | 2016 | 446 | 1.680 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 9 | 2012 | 20 | 1.260 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2014 | 187 | 1.150 |
Why?
|
| Lectins | 7 | 2016 | 484 | 1.110 |
Why?
|
| Mannose-Binding Lectins | 6 | 2013 | 96 | 1.030 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 14 | 2014 | 28 | 1.020 |
Why?
|
| Complement Pathway, Alternative | 12 | 2014 | 116 | 1.010 |
Why?
|
| Teichoic Acids | 6 | 2016 | 70 | 0.870 |
Why?
|
| Thrombin | 5 | 2021 | 590 | 0.870 |
Why?
|
| Staphylococcal Infections | 9 | 2016 | 1406 | 0.830 |
Why?
|
| Complement C3 | 9 | 2012 | 451 | 0.800 |
Why?
|
| Complement Factor B | 3 | 2021 | 72 | 0.800 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2013 | 250 | 0.770 |
Why?
|
| Complement System Proteins | 9 | 2016 | 782 | 0.740 |
Why?
|
| Influenza A virus | 5 | 2014 | 457 | 0.730 |
Why?
|
| Trypsin | 1 | 2021 | 496 | 0.700 |
Why?
|
| Staphylococcus aureus | 12 | 2016 | 1460 | 0.690 |
Why?
|
| Collectins | 4 | 2016 | 18 | 0.670 |
Why?
|
| Cell Wall | 5 | 2016 | 425 | 0.650 |
Why?
|
| Immunity, Innate | 12 | 2016 | 3047 | 0.560 |
Why?
|
| Arthritis, Experimental | 7 | 2013 | 291 | 0.530 |
Why?
|
| Mice, Knockout | 40 | 2021 | 14354 | 0.480 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2013 | 119 | 0.450 |
Why?
|
| Antiviral Agents | 6 | 2013 | 3056 | 0.440 |
Why?
|
| Immunoglobulin G | 10 | 2016 | 4540 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 37 | 2024 | 22003 | 0.420 |
Why?
|
| Mice | 68 | 2024 | 81101 | 0.410 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2013 | 356 | 0.400 |
Why?
|
| Disease Susceptibility | 6 | 2011 | 1788 | 0.380 |
Why?
|
| Blood Coagulation | 3 | 2011 | 1149 | 0.370 |
Why?
|
| Phagocytosis | 9 | 2016 | 1533 | 0.370 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2012 | 83 | 0.370 |
Why?
|
| Inflammation | 15 | 2014 | 10718 | 0.360 |
Why?
|
| Reperfusion Injury | 8 | 2012 | 1022 | 0.350 |
Why?
|
| Animals | 81 | 2024 | 167768 | 0.340 |
Why?
|
| Influenza, Human | 4 | 2016 | 1516 | 0.290 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2016 | 447 | 0.280 |
Why?
|
| Immunologic Factors | 2 | 2013 | 1585 | 0.280 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 3733 | 0.280 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 694 | 0.280 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2006 | 66 | 0.270 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2006 | 67 | 0.270 |
Why?
|
| Complement C1q | 8 | 2012 | 94 | 0.270 |
Why?
|
| Complement Pathway, Classical | 6 | 2014 | 92 | 0.270 |
Why?
|
| Horse Diseases | 1 | 2006 | 54 | 0.260 |
Why?
|
| Dermis | 1 | 2007 | 202 | 0.260 |
Why?
|
| Positron-Emission Tomography | 7 | 2024 | 6457 | 0.250 |
Why?
|
| Radiopharmaceuticals | 5 | 2024 | 2634 | 0.250 |
Why?
|
| Burns | 2 | 2007 | 1848 | 0.240 |
Why?
|
| Antibody Formation | 2 | 2010 | 1400 | 0.240 |
Why?
|
| Ebolavirus | 3 | 2013 | 251 | 0.240 |
Why?
|
| Opsonin Proteins | 5 | 2016 | 147 | 0.230 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 293 | 0.230 |
Why?
|
| Epidermis | 1 | 2007 | 528 | 0.230 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3208 | 0.230 |
Why?
|
| Mannose | 3 | 2010 | 121 | 0.220 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.210 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 30 | 0.210 |
Why?
|
| Radioactive Tracers | 1 | 2022 | 66 | 0.210 |
Why?
|
| 4-Aminopyridine | 1 | 2022 | 80 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 2 | 2014 | 3826 | 0.200 |
Why?
|
| Thiourea | 1 | 2022 | 68 | 0.200 |
Why?
|
| Disease Models, Animal | 14 | 2018 | 18119 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 621 | 0.190 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1066 | 0.190 |
Why?
|
| Immunoglobulin M | 5 | 2010 | 1529 | 0.180 |
Why?
|
| Calcium Channels, L-Type | 1 | 2022 | 240 | 0.180 |
Why?
|
| Isoflurane | 1 | 2024 | 384 | 0.180 |
Why?
|
| Glycoproteins | 4 | 2016 | 2205 | 0.180 |
Why?
|
| Immunization | 4 | 2016 | 1227 | 0.180 |
Why?
|
| Communicable Diseases | 2 | 2008 | 877 | 0.180 |
Why?
|
| Antibodies, Bacterial | 4 | 2016 | 1468 | 0.180 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 351 | 0.170 |
Why?
|
| Peritonitis | 1 | 2002 | 369 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 748 | 0.170 |
Why?
|
| Myocardium | 4 | 2012 | 4690 | 0.160 |
Why?
|
| Complement C4 | 5 | 2012 | 244 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2008 | 17768 | 0.160 |
Why?
|
| Collagen Type II | 2 | 2009 | 148 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 2004 | 0.150 |
Why?
|
| Phylogeny | 2 | 2021 | 2774 | 0.150 |
Why?
|
| Phagosomes | 2 | 2010 | 199 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2006 | 1296 | 0.140 |
Why?
|
| Molecular Imaging | 2 | 2022 | 815 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 5 | 2012 | 513 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 2 | 2011 | 392 | 0.140 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 590 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 405 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2753 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 203 | 0.130 |
Why?
|
| Macrophages, Alveolar | 2 | 2014 | 409 | 0.130 |
Why?
|
| Neuralgia | 1 | 2022 | 600 | 0.130 |
Why?
|
| Complement C6 | 2 | 2012 | 21 | 0.130 |
Why?
|
| Polysaccharides | 3 | 2012 | 1007 | 0.130 |
Why?
|
| Adipocytes | 2 | 2013 | 1177 | 0.130 |
Why?
|
| Models, Biological | 3 | 2012 | 9460 | 0.120 |
Why?
|
| Liver | 3 | 2010 | 7502 | 0.120 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1751 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 699 | 0.120 |
Why?
|
| Brain | 5 | 2024 | 26947 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 77 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13447 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2016 | 354 | 0.120 |
Why?
|
| Extracorporeal Circulation | 1 | 2014 | 182 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 478 | 0.110 |
Why?
|
| Filoviridae Infections | 1 | 2013 | 6 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 116 | 0.110 |
Why?
|
| Neutrophils | 4 | 2016 | 3765 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2016 | 574 | 0.110 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2011 | 87 | 0.110 |
Why?
|
| Binding Sites | 2 | 2021 | 6036 | 0.110 |
Why?
|
| Receptors, Mitogen | 1 | 2013 | 61 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 441 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3339 | 0.110 |
Why?
|
| Artificial Organs | 1 | 2014 | 149 | 0.110 |
Why?
|
| Receptors, Complement | 2 | 2011 | 253 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3801 | 0.100 |
Why?
|
| Solubility | 3 | 2010 | 1088 | 0.100 |
Why?
|
| Cell Division | 1 | 2020 | 4458 | 0.100 |
Why?
|
| Onium Compounds | 1 | 2012 | 27 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2012 | 728 | 0.100 |
Why?
|
| Ligands | 3 | 2022 | 3258 | 0.100 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 8 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 83 | 0.100 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2011 | 50 | 0.100 |
Why?
|
| Autoradiography | 1 | 2013 | 730 | 0.100 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2020 | 2930 | 0.100 |
Why?
|
| Cryptococcus | 1 | 2011 | 28 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6520 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2013 | 196 | 0.100 |
Why?
|
| Spleen | 3 | 2014 | 2296 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2010 | 241 | 0.100 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.100 |
Why?
|
| Antigens, Fungal | 1 | 2011 | 69 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 349 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2010 | 12 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 285 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2014 | 5098 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 203 | 0.090 |
Why?
|
| Leukocytes | 2 | 2013 | 2025 | 0.090 |
Why?
|
| Epitopes | 2 | 2016 | 2502 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2010 | 34 | 0.090 |
Why?
|
| Chagas Disease | 1 | 2012 | 167 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 229 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1878 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 164 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 206 | 0.090 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 301 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2010 | 199 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 4342 | 0.090 |
Why?
|
| Complement C3a | 2 | 2011 | 66 | 0.090 |
Why?
|
| Viral Load | 4 | 2016 | 3321 | 0.090 |
Why?
|
| Protein Binding | 6 | 2016 | 9311 | 0.090 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2009 | 1 | 0.090 |
Why?
|
| Complement Inactivator Proteins | 1 | 2009 | 77 | 0.090 |
Why?
|
| Phagocytes | 1 | 2011 | 296 | 0.080 |
Why?
|
| Complement Factor D | 4 | 2011 | 66 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 117 | 0.080 |
Why?
|
| Complement Factor H | 1 | 2009 | 109 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2013 | 494 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 10748 | 0.080 |
Why?
|
| Hemangioma | 1 | 1994 | 727 | 0.080 |
Why?
|
| Coxiella burnetii | 1 | 2009 | 37 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 747 | 0.080 |
Why?
|
| Humans | 45 | 2021 | 758406 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2379 | 0.080 |
Why?
|
| Cytokines | 6 | 2019 | 7338 | 0.080 |
Why?
|
| Hepatitis B Antibodies | 1 | 2009 | 157 | 0.080 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 11070 | 0.080 |
Why?
|
| Virus Replication | 2 | 2016 | 2430 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2008 | 346 | 0.080 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Macrophages | 3 | 2012 | 5737 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2618 | 0.070 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2007 | 15 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 808 | 0.070 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 503 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 819 | 0.070 |
Why?
|
| Choroidal Neovascularization | 1 | 2011 | 357 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 58 | 0.070 |
Why?
|
| Rats | 5 | 2022 | 23679 | 0.070 |
Why?
|
| Complement C4b | 1 | 2007 | 132 | 0.070 |
Why?
|
| Pneumonia | 1 | 2019 | 2129 | 0.070 |
Why?
|
| Dimerization | 1 | 2008 | 888 | 0.070 |
Why?
|
| Blister | 1 | 2007 | 86 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6548 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1593 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 732 | 0.070 |
Why?
|
| Sepsis | 2 | 2014 | 2587 | 0.070 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.070 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2012 | 570 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1519 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 513 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 223 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 581 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 361 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 9468 | 0.060 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 420 | 0.060 |
Why?
|
| Cell Line | 5 | 2013 | 15591 | 0.060 |
Why?
|
| Brain Injuries | 2 | 2008 | 2044 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2009 | 534 | 0.060 |
Why?
|
| Horses | 1 | 2006 | 298 | 0.060 |
Why?
|
| Models, Animal | 2 | 2008 | 2112 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3584 | 0.060 |
Why?
|
| Dermatitis | 1 | 2007 | 200 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 1323 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 222 | 0.060 |
Why?
|
| Permeability | 2 | 2022 | 718 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10416 | 0.060 |
Why?
|
| Disulfiram | 1 | 2024 | 63 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2013 | 5031 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2007 | 661 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 324 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 191 | 0.050 |
Why?
|
| Male | 23 | 2024 | 358747 | 0.050 |
Why?
|
| Risk Factors | 4 | 2014 | 73809 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2004 | 400 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2013 | 4087 | 0.050 |
Why?
|
| Kinetics | 2 | 2010 | 6371 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2008 | 4113 | 0.050 |
Why?
|
| Bacteremia | 2 | 2005 | 980 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4567 | 0.050 |
Why?
|
| Colitis | 1 | 2010 | 1229 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2176 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1792 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9160 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3664 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 621 | 0.050 |
Why?
|
| Fluorine Radioisotopes | 1 | 2024 | 413 | 0.050 |
Why?
|
| Calcium | 2 | 2012 | 5721 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 18358 | 0.050 |
Why?
|
| Cells, Cultured | 6 | 2016 | 18940 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2004 | 478 | 0.050 |
Why?
|
| Haplotypes | 1 | 2007 | 2764 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 1955 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2016 | 48 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17617 | 0.050 |
Why?
|
| Pneumocystis | 1 | 2000 | 55 | 0.050 |
Why?
|
| Mycoses | 1 | 2004 | 386 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2024 | 564 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 792 | 0.040 |
Why?
|
| Movement | 1 | 2007 | 1474 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 523 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3533 | 0.040 |
Why?
|
| Kidney | 3 | 2010 | 7016 | 0.040 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 726 | 0.040 |
Why?
|
| Retina | 1 | 2011 | 2635 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 161 | 0.040 |
Why?
|
| Lung | 5 | 2011 | 9985 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1262 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3299 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3020 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 829 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2024 | 574 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2006 | 755 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3047 | 0.040 |
Why?
|
| Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2000 | 242 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3301 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2002 | 559 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 2189 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 1275 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2723 | 0.040 |
Why?
|
| Female | 15 | 2018 | 390323 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 264 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2007 | 2860 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1401 | 0.040 |
Why?
|
| RNA Interference | 1 | 2006 | 2836 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 585 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9518 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2005 | 1358 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2016 | 81 | 0.030 |
Why?
|
| Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1274 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 46 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 1018 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 1444 | 0.030 |
Why?
|
| Complement C2 | 2 | 2005 | 70 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2825 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4738 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 16534 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12436 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 10112 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2666 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 83 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 97 | 0.030 |
Why?
|
| Aged | 6 | 2018 | 168218 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1680 | 0.030 |
Why?
|
| Collagenases | 1 | 1994 | 221 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2007 | 3220 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3096 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 262 | 0.030 |
Why?
|
| Mast Cells | 2 | 2006 | 1390 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 283 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 2244 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11471 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8544 | 0.030 |
Why?
|
| Pinocytosis | 1 | 2013 | 62 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 289 | 0.030 |
Why?
|
| Brain Edema | 2 | 2008 | 603 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2016 | 541 | 0.030 |
Why?
|
| Complement Fixation Tests | 1 | 2012 | 71 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2012 | 57 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 172 | 0.030 |
Why?
|
| Heart | 1 | 2006 | 4382 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 695 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1926 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 105 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 3755 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1994 | 747 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 3840 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6201 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1969 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 167 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6362 | 0.030 |
Why?
|
| Pandemics | 1 | 2012 | 8611 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2005 | 604 | 0.030 |
Why?
|
| Vero Cells | 1 | 2013 | 482 | 0.020 |
Why?
|
| Endotoxins | 1 | 2014 | 521 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 590 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1845 | 0.020 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 672 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 41256 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4902 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3480 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 979 | 0.020 |
Why?
|
| Flavonoids | 1 | 2014 | 443 | 0.020 |
Why?
|
| Magnetics | 1 | 2014 | 600 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 8143 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3432 | 0.020 |
Why?
|
| Lymphokines | 1 | 1994 | 926 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 196 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 632 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14641 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1844 | 0.020 |
Why?
|
| Rabbits | 2 | 2007 | 4772 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 428 | 0.020 |
Why?
|
| Middle Aged | 5 | 2014 | 219568 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2014 | 4215 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9694 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2013 | 524 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 377 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1895 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9574 | 0.020 |
Why?
|
| Immune System | 2 | 2008 | 796 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 247 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2011 | 395 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 64378 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 609 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 638 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3521 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 114 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 275 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 367 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6068 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 278 | 0.020 |
Why?
|
| Chlorides | 1 | 2011 | 663 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 517 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5864 | 0.020 |
Why?
|
| Q Fever | 1 | 2009 | 38 | 0.020 |
Why?
|
| Oximetry | 1 | 2012 | 460 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3705 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 815 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1370 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2009 | 301 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 803 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 303 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20055 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5892 | 0.020 |
Why?
|
| Candidiasis | 1 | 2010 | 363 | 0.020 |
Why?
|
| Microscopy | 1 | 2013 | 884 | 0.020 |
Why?
|
| Zymosan | 1 | 2007 | 136 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1389 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 168 | 0.020 |
Why?
|
| Collagen Type VII | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 961 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 374 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2009 | 388 | 0.020 |
Why?
|
| Immune Sera | 1 | 2007 | 613 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 552 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4938 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 481 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 390 | 0.020 |
Why?
|
| Adult | 7 | 2013 | 219935 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2009 | 616 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2006 | 70 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2009 | 23342 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2426 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11424 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 36055 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3507 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1659 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 29915 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15773 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 401 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3796 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2012 | 1561 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2129 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 202 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 1349 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 6209 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2007 | 286 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 2038 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2497 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 622 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 477 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 123 | 0.020 |
Why?
|
| Troponin I | 1 | 2009 | 632 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 58683 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15637 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1049 | 0.020 |
Why?
|
| Asthma | 1 | 2004 | 6172 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 402 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1759 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 16886 | 0.010 |
Why?
|
| Hypothermia | 1 | 2006 | 188 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 673 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 237 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6234 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 877 | 0.010 |
Why?
|
| Encephalitis | 1 | 2008 | 438 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3845 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4257 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12759 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2013 | 26183 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 2020 | 0.010 |
Why?
|
| Herpes Genitalis | 1 | 2004 | 142 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1155 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 344 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2646 | 0.010 |
Why?
|
| Dextrans | 1 | 2005 | 573 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 769 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 449 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2006 | 801 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7985 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 583 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 156 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1668 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2007 | 716 | 0.010 |
Why?
|
| Autoantigens | 1 | 2006 | 877 | 0.010 |
Why?
|
| Germinal Center | 1 | 2005 | 378 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 605 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 1825 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2012 | 4159 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8945 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 964 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2000 | 85 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1604 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1514 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 1944 | 0.010 |
Why?
|
| Monosaccharides | 1 | 2000 | 68 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 1356 | 0.010 |
Why?
|
| Weight Loss | 1 | 2011 | 2671 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3824 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2695 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 5786 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1994 | 11152 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2189 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1885 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 1456 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1411 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20500 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1020 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 4809 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2007 | 2118 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2000 | 681 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 1919 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2413 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2010 | 2275 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2204 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2970 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4284 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4919 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2000 | 662 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3858 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5952 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1906 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1699 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3602 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2009 | 5460 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2626 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 1155 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 5490 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 87892 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12945 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11892 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8426 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 8451 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 42062 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 3997 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15225 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14490 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 12721 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2007 | 12094 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72136 | 0.000 |
Why?
|
| Child | 1 | 1994 | 79818 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 58808 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6850 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 54137 | 0.000 |
Why?
|
| HIV Infections | 1 | 2000 | 17275 | 0.000 |
Why?
|